MeiraGTx (MGTX.US) reached a collaboration on gene therapy with LLY.US, and saw a big surge in pre-market trading.

According to the Securities Times app, the stock price of gene therapy company MeiraGTx Holdings (MGTX.US) rose 13.22% in pre-market trading on Monday. Prior to this, the company announced a broad strategic partnership with Eli Lilly (LLY.US) to jointly develop and commercialize gene therapies for ocular diseases.